gener
regard
broadspectrum
regulatori
cytokin
howev
role
cell
remain
controversi
studi
investig
characterist
endogen
cell
gastric
cancer
gc
patient
use
intracellular
stain
found
gc
patient
healthi
control
major
cell
also
present
concurr
ifng
express
interestingli
frequenc
ifng
cell
significantli
higher
gc
patient
healthi
control
frequenc
ifng
cell
significantli
lower
gc
patient
healthi
control
compar
ifng
cell
ifng
ifng
cell
present
significantli
higher
express
activationinhibitori
marker
interestingli
ifng
cell
present
lower
higher
ifng
cell
remark
ifng
cell
ifng
cell
highli
enrich
subset
prolong
activ
result
signific
enrich
ifng
cell
time
interestingli
compar
cell
cell
present
stronger
prolifer
capac
later
stage
stimul
higher
viabil
throughout
stimul
process
overal
investig
demonstr
gc
patient
enrich
distinct
popul
ifng
doubl
posit
cell
resembl
follicular
cytotox
cell
could
persist
longer
prolong
activ
gastric
cancer
gc
one
common
caus
cancerrel
death
worldwid
develop
strongli
link
helicobact
pylori
h
pylori
infect
howev
tini
fraction
h
pyloriinfect
individu
eventu
develop
gc
major
infect
case
remain
asymptomat
life
understood
chronic
inflammatori
respons
initi
h
pylori
critic
contribut
gc
pathogenesi
typic
start
antral
region
incit
inflammatori
respons
h
pylorimedi
inflamm
gradual
spread
upper
stomach
time
caus
increasingli
sever
mucos
atrophi
intestin
metaplasia
malign
transform
gastric
line
mani
branch
immun
system
involv
process
h
pylori
could
directli
elev
express
spermin
oxidas
gastric
epitheli
cell
macrophag
induc
dna
damag
product
reactiv
oxygen
speci
h
pylori
high
salt
diet
also
synergist
increas
product
sever
proinflammatori
cytokin
tnf
possess
angiogen
prometastat
role
tumor
adapt
immun
respons
involv
b
cell
cell
like
also
contribut
gc
initi
mice
infect
helicobact
spp
show
symptom
human
gc
patient
b
cell
cell
absent
evid
demonstr
ifng
respons
contribut
gastric
atrophi
mice
infect
helicobact
spp
gc
suppress
tumor
establish
metaanalysi
tumorinfiltr
lymphocyt
til
gc
patient
indic
frequenc
tumorinfiltr
cell
especi
til
posit
associ
overal
surviv
high
express
transcript
factor
regulatori
cell
til
associ
reduc
surviv
high
tumorinfiltr
cell
frequenc
addit
associ
lower
lymph
node
metastasi
reduc
recurr
follow
surgic
resect
pleiotrop
cytokin
multipl
protect
role
inflamm
shown
suppress
innat
adapt
immun
respons
mediat
tissu
repair
maintain
epithelium
integr
addit
directli
dampen
signal
transduct
cell
thu
increas
threshold
requir
antigen
recognit
activ
interestingli
polymorph
increas
product
associ
elev
gc
risk
contrari
hypothesi
may
prevent
inflammationinduc
disrupt
epithelium
also
evid
promot
activ
expans
tumorresid
cell
murin
tumor
studi
contrast
common
notion
inhibit
cell
respons
studi
investig
endogen
product
cell
gc
patient
interestingli
found
cell
produc
cytokin
could
separ
two
distinct
subset
ifng
posit
type
ifng
doubl
posit
type
latter
enrich
gc
patient
two
subset
differ
cytokin
product
also
differ
express
surfac
marker
exhaust
marker
prolifer
surviv
capac
studi
includ
patient
primari
gastric
adenocarcinoma
includ
stage
ii
stage
iii
patient
defin
american
joint
committe
cancer
patient
h
pylori
infect
total
ageand
sexmatch
healthi
volunt
recruit
control
demograph
data
patient
control
present
tabl
exclus
criteria
age
outsid
year
rang
famili
histori
gc
previou
ongo
chemotherapi
radiat
therapi
autoimmun
condit
malign
patient
control
donat
ml
peripher
blood
sampl
peripher
blood
mononuclear
cell
pbmc
harvest
ficol
densiti
gradient
centrifug
diagnosi
sampl
collect
experiment
perform
hospit
follow
approv
ethic
committe
hospit
particip
provid
written
inform
consent
cell
isol
total
pbmc
via
neg
magnet
select
use
easysep
human
cell
enrich
kit
stemcel
puriti
assess
stain
cell
consist
cell
incub
rpmi
supplement
lglutamin
penicillinstreptomycin
fetal
bovin
serum
gibco
stimul
human
activ
bead
gibco
ad
bead
per
cell
gibco
supplement
medium
replac
everi
day
time
point
specifi
experi
centrifug
perform
g
min
separ
cell
supernat
violet
dead
cell
stain
invitrogen
differ
combin
surfac
antihuman
stain
antibodi
biolegend
includ
ad
min
ice
cell
wash
twice
centrifug
min
permeabil
use
cytofixcytoperm
bd
min
ice
wash
intracellular
stain
antibodi
biolegend
includ
ifng
ad
min
ice
perm
wash
buffer
bd
sampl
wash
twice
acquir
bd
lsr
instrument
experi
lymphocyt
minimum
collect
ifng
concentr
measur
use
respect
human
elisa
kit
invitrogen
accord
manufactur
instruct
standard
curv
establish
use
pure
cytokin
sampl
includ
kit
cell
magnet
neg
select
incub
antihuman
min
ice
cell
cell
sort
use
facsaria
instrument
bd
follow
stimul
cell
plate
cell
per
well
plate
incub
tritiat
thymidin
amersham
bioscienc
hour
radioact
count
liquid
scintil
counter
data
given
scatterplot
mean
sd
distribut
examin
use
dagostinopearson
test
differ
group
examin
use
test
specifi
figur
legend
twotail
p
consid
signific
recruit
gc
patient
healthi
control
circul
cell
isol
total
pbmc
use
magnet
sort
isol
cell
treat
stimul
cytokin
product
use
intracellular
stain
identifi
ifngexpress
cell
subject
fig
frequenc
ifngexpress
ifng
cell
mean
sem
healthi
control
significantli
lower
gc
patient
fig
frequenc
ifngexpress
ifng
cell
hand
healthi
control
markedli
higher
gc
patient
fig
frequenc
total
ifngexpress
ifng
ifng
cell
healthi
control
slightli
lower
gc
patient
fig
overal
data
demonstr
gc
patient
present
upregul
character
posit
cell
popul
gc
patient
investig
surfac
marker
express
cell
first
express
inhibitori
marker
includ
examin
flow
cytometri
fig
compar
cell
express
ifng
ifng
ifng
cell
present
significantli
higher
express
fig
c
interestingli
ifng
cell
present
significantli
higher
express
ifng
significantli
lower
express
ifng
express
also
higher
ifng
cell
ifng
cell
fig
ifng
cell
present
slightli
higher
ifng
cell
express
pattern
ifng
cell
strongli
resembl
express
pattern
follicular
cytotox
tfc
cell
previous
character
chronic
lcmv
infect
henc
express
examin
fig
c
averag
half
ifng
cell
fig
ifng
ifng
cell
hand
predominantli
frequenc
cell
ifng
cell
significantli
higher
ifng
cell
fig
frequenc
lower
ifng
cell
gc
patient
fig
ifng
cell
howev
averag
remark
ifng
cell
cell
averag
subsequ
sort
total
cell
cell
cell
subset
treat
vitro
hour
ifng
product
measur
use
multiplex
assay
cell
cell
display
markedli
differ
capac
product
former
express
high
level
latter
express
minim
detect
fig
cell
cell
readili
express
ifng
cell
potent
fig
togeth
data
demonstr
ifng
cell
display
lower
ifng
cell
could
enrich
cell
fraction
ifng
cell
enrich
prolong
stimul
examin
dynam
ifng
express
follow
extend
stimul
cell
sort
pbmc
stimul
total
day
frequenc
ifng
ifng
cell
examin
day
day
day
day
day
stimul
fig
frequenc
ifng
cell
increas
day
day
decreas
day
day
frequenc
ifng
cell
hand
increas
continu
day
day
day
frequenc
ifng
significantli
product
cell
follow
stimul
use
bead
b
ifng
product
cell
follow
stimul
use
bead
student
ttest
p
p
c
zhong
et
al
experiment
cell
research
higher
frequenc
ifng
cell
day
day
howev
signific
differ
observ
supernat
detect
cytokin
concentr
supernat
harvest
time
point
concentr
present
increas
trend
compar
concentr
day
concentr
day
day
significantli
higher
fig
ifng
hand
increas
initi
decreas
day
compar
ifng
concentr
day
ifng
concentr
higher
day
day
compar
day
lower
day
fig
cell
present
better
prolifer
lower
death
cell
assess
prolifer
capac
ifng
ifng
cell
took
advantag
observ
ifng
cell
enrich
cell
total
cell
sort
subset
stimul
vitro
prolifer
capac
examin
use
thymidin
incorpor
assay
fig
prolifer
capac
cell
significantli
higher
fig
prolifer
viabil
cell
cell
stimul
use
bead
everi
day
portion
cell
harvest
determin
prolifer
capac
viabil
radioact
thymidin
incorpor
cell
puls
tritiat
thymidin
b
viabil
cell
measur
use
violet
dead
cell
stain
b
twoway
anova
follow
sidak
multipl
comparison
p
p
p
c
zhong
et
al
experiment
cell
research
cell
day
day
quickli
declin
day
day
prolifer
capac
cell
continu
increas
exceed
cell
viabil
cell
examin
use
flow
cytometri
throughout
cours
stimul
cell
present
higher
viabil
cell
fig
gener
regard
broadspectrum
regulatori
cytokin
dampen
inflammatori
respons
includ
mediat
cell
gc
patient
express
level
posit
associ
densiti
microvessel
neg
associ
cell
infiltr
tumor
howev
appear
often
accompani
inhibitori
immun
cell
regulatori
b
cell
regulatori
dendrit
cell
macrophag
tumorassoci
macrophag
henc
suppress
effect
previous
describ
studi
might
requir
coexist
inhibitori
molecul
cell
type
inde
receptor
express
cell
shown
strongli
induc
phosphoryl
promot
situ
prolifer
tumorresid
cell
addit
coronavirusinfect
murin
enceph
model
cell
produc
display
higher
cytokin
chemokin
express
stronger
cytolyt
activ
studi
investig
cell
express
endogen
healthi
control
gc
patient
cell
express
could
observ
follow
stimul
interestingli
posit
cell
rare
major
cell
also
present
concurr
ifng
express
gc
patient
posit
cell
healthi
control
healthi
control
ifngsingl
posit
cell
gc
patient
seem
suggest
posit
cell
popul
aros
due
diseas
later
found
prolong
stimul
alon
could
result
higher
level
posit
cell
lower
level
ifngsingl
posit
cell
henc
possibl
cell
gc
patient
continu
challeng
tumor
antigen
andor
h
pylori
antigen
result
prolong
activ
higher
frequenc
posit
cell
futur
antigen
specif
posit
cell
investig
major
limit
studi
conclus
demonstr
function
posit
cell
gastric
cancer
patient
found
certain
featur
posit
cell
subset
includ
lower
lower
higher
resembl
tfc
cell
inde
found
posit
cell
highli
enrich
cell
ifngsingl
posit
cell
enrich
cell
featur
would
help
us
demonstr
role
posit
cell
anim
model
use
delet
adopt
transfer
past
research
tfc
cell
shown
present
stronger
prolifer
respons
blockad
exhaust
cell
suggest
might
candid
antitumor
immunotherapi
howev
regulatori
function
also
demonstr
cell
exampl
cell
shown
inhibit
graftversushost
diseas
vivo
suppress
naiv
effector
cell
activ
iggig
product
interestingli
cellmedi
shown
resolv
chemotherapyinduc
neuropath
pain
henc
express
might
serv
multipl
role
cell
function
posit
cell
investig
use
anim
model
none
